NVST Quote, Financials, Valuation and Earnings

Align Technology, Inc. has a net margin of -4.52% compared to Envista Holdings Corp.'s net margin of 5.7%. Envista Holdings Corp.'s return on equity of 0.5% beat Align Technology, Inc.'s return on equity of 9.72%.

Envista Holdings Corp. has a consensus price target of $22.00, signalling upside risk potential of 7.58%. On the other hand Align Technology, Inc. has an analysts' consensus of $184.07 which suggests that it could grow by 17.36%. Given that Align Technology, Inc. has higher upside potential than Envista Holdings Corp., analysts believe Align Technology, Inc. is more attractive than Envista Holdings Corp..

Envista Holdings Corp. has a beta of 1.025, which suggesting that the stock is 2.453% more volatile than S&P 500. In comparison Align Technology, Inc. has a beta of 1.860, suggesting its more volatile than the S&P 500 by 85.974%.

Envista Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Align Technology, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Envista Holdings Corp. pays -- of its earnings as a dividend. Align Technology, Inc. pays out -- of its earnings as a dividend.

Envista Holdings Corp. quarterly revenues are $669.9M, which are smaller than Align Technology, Inc. quarterly revenues of $995.7M. Envista Holdings Corp.'s net income of -$30.3M is lower than Align Technology, Inc.'s net income of $56.8M. Notably, Envista Holdings Corp.'s price-to-earnings ratio is 244.62x while Align Technology, Inc.'s PE ratio is 30.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings Corp. is 1.33x versus 2.89x for Align Technology, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Phibro Animal Health Corp. has a net margin of -4.52% compared to Envista Holdings Corp.'s net margin of 7.29%. Envista Holdings Corp.'s return on equity of 0.5% beat Phibro Animal Health Corp.'s return on equity of 24.77%.

Envista Holdings Corp. has a consensus price target of $22.00, signalling upside risk potential of 7.58%. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 3.89%. Given that Envista Holdings Corp. has higher upside potential than Phibro Animal Health Corp., analysts believe Envista Holdings Corp. is more attractive than Phibro Animal Health Corp..

Envista Holdings Corp. has a beta of 1.025, which suggesting that the stock is 2.453% more volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.

Envista Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Phibro Animal Health Corp. offers a yield of 1.16% to investors and pays a quarterly dividend of $0.12 per share. Envista Holdings Corp. pays -- of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Envista Holdings Corp. quarterly revenues are $669.9M, which are larger than Phibro Animal Health Corp. quarterly revenues of $363.9M. Envista Holdings Corp.'s net income of -$30.3M is lower than Phibro Animal Health Corp.'s net income of $26.5M. Notably, Envista Holdings Corp.'s price-to-earnings ratio is 244.62x while Phibro Animal Health Corp.'s PE ratio is 24.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings Corp. is 1.33x versus 1.21x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

West Pharmaceutical Services, Inc. has a net margin of -4.52% compared to Envista Holdings Corp.'s net margin of 17.41%. Envista Holdings Corp.'s return on equity of 0.5% beat West Pharmaceutical Services, Inc.'s return on equity of 17.44%.

Envista Holdings Corp. has a consensus price target of $22.00, signalling upside risk potential of 7.58%. On the other hand West Pharmaceutical Services, Inc. has an analysts' consensus of $346.07 which suggests that it could grow by 21.72%. Given that West Pharmaceutical Services, Inc. has higher upside potential than Envista Holdings Corp., analysts believe West Pharmaceutical Services, Inc. is more attractive than Envista Holdings Corp..

Envista Holdings Corp. has a beta of 1.025, which suggesting that the stock is 2.453% more volatile than S&P 500. In comparison West Pharmaceutical Services, Inc. has a beta of 1.166, suggesting its more volatile than the S&P 500 by 16.617%.

Envista Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. West Pharmaceutical Services, Inc. offers a yield of 0.3% to investors and pays a quarterly dividend of $0.22 per share. Envista Holdings Corp. pays -- of its earnings as a dividend. West Pharmaceutical Services, Inc. pays out 12.27% of its earnings as a dividend. West Pharmaceutical Services, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Envista Holdings Corp. quarterly revenues are $669.9M, which are smaller than West Pharmaceutical Services, Inc. quarterly revenues of $804.3M. Envista Holdings Corp.'s net income of -$30.3M is lower than West Pharmaceutical Services, Inc.'s net income of $140M. Notably, Envista Holdings Corp.'s price-to-earnings ratio is 244.62x while West Pharmaceutical Services, Inc.'s PE ratio is 42.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings Corp. is 1.33x versus 6.86x for West Pharmaceutical Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Dentsply Sirona, Inc. has a net margin of -4.52% compared to Envista Holdings Corp.'s net margin of -47.35%. Envista Holdings Corp.'s return on equity of 0.5% beat Dentsply Sirona, Inc.'s return on equity of -44.58%.

Envista Holdings Corp. has a consensus price target of $22.00, signalling upside risk potential of 7.58%. On the other hand Dentsply Sirona, Inc. has an analysts' consensus of $12.96 which suggests that it could grow by 14.37%. Given that Dentsply Sirona, Inc. has higher upside potential than Envista Holdings Corp., analysts believe Dentsply Sirona, Inc. is more attractive than Envista Holdings Corp..

Envista Holdings Corp. has a beta of 1.025, which suggesting that the stock is 2.453% more volatile than S&P 500. In comparison Dentsply Sirona, Inc. has a beta of 1.008, suggesting its more volatile than the S&P 500 by 0.82100000000001%.

Envista Holdings Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona, Inc. offers a yield of 5.65% to investors and pays a quarterly dividend of $0.16 per share. Envista Holdings Corp. pays -- of its earnings as a dividend. Dentsply Sirona, Inc. pays out 13.85% of its earnings as a dividend. Dentsply Sirona, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Envista Holdings Corp. quarterly revenues are $669.9M, which are smaller than Dentsply Sirona, Inc. quarterly revenues of $904M. Envista Holdings Corp.'s net income of -$30.3M is higher than Dentsply Sirona, Inc.'s net income of -$428M. Notably, Envista Holdings Corp.'s price-to-earnings ratio is 244.62x while Dentsply Sirona, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Envista Holdings Corp. is 1.33x versus 0.62x for Dentsply Sirona, Inc.. Usually stocks with elevated PS ratios are considered overvalued.